SG11202009009UA - Viral and non-viral nanoplasmid vectors with improved production - Google Patents
Viral and non-viral nanoplasmid vectors with improved productionInfo
- Publication number
- SG11202009009UA SG11202009009UA SG11202009009UA SG11202009009UA SG11202009009UA SG 11202009009U A SG11202009009U A SG 11202009009UA SG 11202009009U A SG11202009009U A SG 11202009009UA SG 11202009009U A SG11202009009U A SG 11202009009UA SG 11202009009U A SG11202009009U A SG 11202009009UA
- Authority
- SG
- Singapore
- Prior art keywords
- viral
- improved production
- nanoplasmid vectors
- nanoplasmid
- vectors
- Prior art date
Links
- 230000003612 virological effect Effects 0.000 title 2
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
- C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/24—Vectors characterised by the absence of particular element, e.g. selectable marker, viral origin of replication
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Carbon And Carbon Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862645892P | 2018-03-21 | 2018-03-21 | |
| PCT/US2019/023209 WO2019183248A1 (fr) | 2018-03-21 | 2019-03-20 | Vecteurs nanoplasmidiques viraux et non viraux à production améliorée |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009009UA true SG11202009009UA (en) | 2020-10-29 |
Family
ID=66001381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009009UA SG11202009009UA (en) | 2018-03-21 | 2019-03-20 | Viral and non-viral nanoplasmid vectors with improved production |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210010021A1 (fr) |
| EP (2) | EP4151735A1 (fr) |
| JP (2) | JP7520719B2 (fr) |
| KR (1) | KR20210016330A (fr) |
| CN (1) | CN112154208A (fr) |
| AU (1) | AU2019240068A1 (fr) |
| CA (1) | CA3093346A1 (fr) |
| DK (1) | DK3768846T5 (fr) |
| ES (1) | ES2950736T3 (fr) |
| FI (1) | FI3768846T3 (fr) |
| LT (1) | LT3768846T (fr) |
| SG (1) | SG11202009009UA (fr) |
| WO (1) | WO2019183248A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202124722A (zh) | 2019-09-18 | 2021-07-01 | 美商英特佳樂帝克醫療公司 | 合成dna載體及其使用方法 |
| EP4243839A1 (fr) | 2020-11-13 | 2023-09-20 | Catamaran Bio, Inc. | Cellules tueuses naturelles génétiquement modifiées et procédés d'utilisation associés |
| AU2022299552A1 (en) | 2021-06-25 | 2024-01-04 | Oxford Biomedica (Us) Llc | Adeno-associated virus packaging systems |
| JP2024531910A (ja) | 2021-08-04 | 2024-09-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイト | Ｌａｔ活性化キメラ抗原受容体ｔ細胞及びその使用方法 |
| CN114045305B (zh) * | 2021-10-15 | 2023-03-24 | 深圳市深研生物科技有限公司 | 多转座子系统 |
| US20230323395A1 (en) | 2021-12-15 | 2023-10-12 | Homology Medicines, Inc. | Methods and compositions for the production of adeno-associated virus |
| WO2023172514A1 (fr) | 2022-03-07 | 2023-09-14 | Catamaran Bio, Inc. | Agents thérapeutiques de cellules immunitaires modifiés ciblés sur her2 et leurs procédés d'utilisation |
| WO2024020320A2 (fr) * | 2022-07-19 | 2024-01-25 | Rampart Bioscience, Inc. | Vecteurs d'adn non immunogènes circulaires non viraux |
| CN117305339B (zh) * | 2023-11-30 | 2024-02-06 | 苏州左旋星生物科技有限公司 | 优化大肠杆菌基因编辑的载体及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04197185A (ja) * | 1990-11-28 | 1992-07-16 | Mitsui Toatsu Chem Inc | 酵母発現ベクター及びこれを用いた誘導的発現 |
| GB9506051D0 (en) * | 1995-03-24 | 1995-05-10 | Univ Singapore | Gene expression |
| FR2738842B1 (fr) | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
| US7279313B2 (en) | 1995-09-15 | 2007-10-09 | Centelion | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| US5922583A (en) | 1995-10-17 | 1999-07-13 | Biostar Inc. | Methods for production of recombinant plasmids |
| US6709844B1 (en) | 2000-11-16 | 2004-03-23 | Mannkind Corporation | Avoidance of undesirable replication intermediates in plasmid propagation |
| JP2004267001A (ja) * | 2000-08-16 | 2004-09-30 | Kansai Tlo Kk | トランスジェニック哺乳動物及びその作製方法並びにこれを用いた遺伝子機能の解明方法 |
| UY26317A1 (es) * | 2000-08-30 | 2000-10-31 | Alfonso Cayota Carlos Pritsch | Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo |
| FR2821855B1 (fr) | 2001-03-09 | 2004-04-02 | Cayla | Genes synthetiques et plasmides bacteriens depourvus de cpg |
| CA2794446C (fr) * | 2001-04-04 | 2015-09-08 | Genencor International, Inc. | Mecanismes d'action productifs et cataboliques non couples des cellules hotes |
| KR20050026384A (ko) * | 2002-04-26 | 2005-03-15 | 내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 | ＲＮＡｉ효과를 가지는 스템 루프 형 ＲＮＡ 분자 발현 시스템 |
| WO2005003359A1 (fr) * | 2003-07-08 | 2005-01-13 | Japan Science And Technology Corporation | Procede et systeme permettant de mettre au point un organisme transgenique |
| GB0327056D0 (en) | 2003-11-20 | 2003-12-24 | Cobra Biolog Ltd | Plasmid maintenance |
| KR20070053765A (ko) | 2004-08-19 | 2007-05-25 | 네이쳐 테크놀로지 코포레이션 | 플라스미드 디엔에이 발효 공정 |
| JP4804467B2 (ja) * | 2004-08-23 | 2011-11-02 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 多重ｒｎａポリメラーゼｉｉｉプロモーター発現構築物 |
| TWI311152B (en) | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
| US9175295B2 (en) * | 2005-07-05 | 2015-11-03 | The Chemo-Sero-Therapeutic Research Institute | Modified transposon vector and its use |
| US9109012B2 (en) | 2007-05-29 | 2015-08-18 | Nature Technology Corporation | Vectors and method for genetic immunization |
| EP2185706B1 (fr) * | 2007-08-14 | 2017-09-27 | Commonwealth Scientific and Industrial Research Organisation | Procédé perfectionné de silençage génique |
| US9045759B2 (en) | 2009-01-21 | 2015-06-02 | James Arthur Williams | DNA plasmids with improved copy number |
| ES2679291T3 (es) * | 2011-12-07 | 2018-08-23 | Glenmark Pharmaceuticals S.A. | Casete de expresión |
| WO2014035457A1 (fr) * | 2012-08-29 | 2014-03-06 | Nature Technology Corporation | Plasmides d'adn dotés d'une expression améliorée |
| WO2014077863A1 (fr) * | 2012-11-19 | 2014-05-22 | Nature Technology Corporation | Vecteurs réplicatifs en minicercle avec une expression améliorée |
| CN105722976A (zh) * | 2013-06-06 | 2016-06-29 | 诺华股份有限公司 | 流感病毒重配 |
| CA3001594A1 (fr) | 2015-10-14 | 2017-04-20 | Audentes Therapeutics, Inc. | Molecules d'acide nucleique contenant des espaceurs et leurs procedes d'utilisation |
| US20220042038A1 (en) * | 2018-12-20 | 2022-02-10 | Poseida Therapeutics, Inc. | Nanotransposon compositions and methods of use |
-
2019
- 2019-03-20 SG SG11202009009UA patent/SG11202009009UA/en unknown
- 2019-03-20 LT LTEPPCT/US2019/023209T patent/LT3768846T/lt unknown
- 2019-03-20 KR KR1020207030139A patent/KR20210016330A/ko unknown
- 2019-03-20 WO PCT/US2019/023209 patent/WO2019183248A1/fr unknown
- 2019-03-20 ES ES19715345T patent/ES2950736T3/es active Active
- 2019-03-20 FI FIEP19715345.5T patent/FI3768846T3/fi active
- 2019-03-20 JP JP2020551263A patent/JP7520719B2/ja active Active
- 2019-03-20 EP EP22194460.6A patent/EP4151735A1/fr active Pending
- 2019-03-20 CN CN201980034026.9A patent/CN112154208A/zh active Pending
- 2019-03-20 DK DK19715345.5T patent/DK3768846T5/da active
- 2019-03-20 AU AU2019240068A patent/AU2019240068A1/en active Pending
- 2019-03-20 EP EP19715345.5A patent/EP3768846B1/fr active Active
- 2019-03-20 CA CA3093346A patent/CA3093346A1/fr active Pending
-
2020
- 2020-09-18 US US17/026,101 patent/US20210010021A1/en active Pending
-
2024
- 2024-07-10 JP JP2024110895A patent/JP2024138410A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3768846B1 (fr) | 2023-06-21 |
| DK3768846T3 (da) | 2023-07-24 |
| EP3768846A1 (fr) | 2021-01-27 |
| CN112154208A (zh) | 2020-12-29 |
| JP2024138410A (ja) | 2024-10-08 |
| WO2019183248A1 (fr) | 2019-09-26 |
| LT3768846T (lt) | 2023-08-10 |
| KR20210016330A (ko) | 2021-02-15 |
| FI3768846T3 (fi) | 2023-06-30 |
| JP2021518150A (ja) | 2021-08-02 |
| JP7520719B2 (ja) | 2024-07-23 |
| CA3093346A1 (fr) | 2019-09-29 |
| EP4151735A1 (fr) | 2023-03-22 |
| ES2950736T3 (es) | 2023-10-13 |
| AU2019240068A1 (en) | 2020-10-01 |
| US20210010021A1 (en) | 2021-01-14 |
| DK3768846T5 (da) | 2024-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202009009UA (en) | Viral and non-viral nanoplasmid vectors with improved production | |
| IL290102A (en) | Viral vectors of cell lysis and their uses | |
| IL271993A (en) | Viral vectors of cell lysis and their uses | |
| LT3670655T (lt) | Proteinazės, turinčios pagerintas savybes | |
| EP3558393A4 (fr) | Vecteurs viraux adéno-associés | |
| IL282885A (en) | AAV viral vectors and their uses | |
| IL253820B (en) | Retrovirus and lentivirus vectors | |
| EP3436576A4 (fr) | Lignée cellulaire pour la production de protéine recombinante et/ou d'un vecteur viral recombinant | |
| SG11202009452WA (en) | Antibody-evading virus vectors | |
| IL282053A (en) | Constructions of glut1-linked recombinant aav vectors, preparations and kits containing them and their use | |
| IL284188A (en) | Adapted orthopoxvirus vectors | |
| IL290258A (en) | Transgenic Isfahan Viral Vector | |
| GB201706945D0 (en) | Self-inactivating viral vector | |
| IL275813A (en) | Adapted orthopoxvirus vectors | |
| HK1253863A1 (zh) | 含prrsv次要蛋白的重組病毒載體及其製造方法與用途 | |
| EP3723813A4 (fr) | Édition génomique à médiation par crispr avec des vecteurs | |
| GB2571415B (en) | Improved tinting shampoos | |
| ZA202108996B (en) | Viral vector | |
| IL287071A (en) | h factor vectors and their uses | |
| ZA202104244B (en) | Recombinant viruses and the uses thereof | |
| HK1255099A1 (zh) | 重組溶瘤病毒及其用途 | |
| EP3597759A4 (fr) | Vecteur viral de borna et son utilisation | |
| PT3250234T (pt) | Mdv1 recombinante e suas utilizações | |
| EP3621982A4 (fr) | Système de production de vecteurs viraux | |
| EP3371312A4 (fr) | Analyse de vecteur viral et vecteur |